GE liver embolization tool cleared by FDA

The FDA has cleared GE Healthcare’s FlightPlan for Liver advanced imaging tool, which is designed to assist interventionalists plan liver embolization procedures by automatically identifying tumor vicinity vessels.

Using GE’s Innova Vision application, a highlighted 3D roadmap of vessels can be superimposed on the live fluoroscopic image, the company said.

The tool has been commercially available in Europe, Latin America and Asia since 2011.

 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.